These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 26886163)

  • 1. Expert Study: Utility of an Automated Bolus Advisor System in Patients with Type 1 Diabetes Treated with Multiple Daily Injections of Insulin-A Crossover Study.
    Gonzalez C; Picón MJ; Tomé M; Pujol I; Fernández-García JC; Chico A
    Diabetes Technol Ther; 2016 May; 18(5):282-7. PubMed ID: 26886163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections.
    Barnard K; Parkin C; Young A; Ashraf M
    J Diabetes Sci Technol; 2012 Jan; 6(1):144-9. PubMed ID: 22401332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent use of an automated bolus advisor improves glycemic control in pediatric patients treated with insulin pump therapy: results of the Bolus Advisor Benefit Evaluation (BABE) study.
    Ziegler R; Rees C; Jacobs N; Parkin CG; Lyden MR; Petersen B; Wagner RS
    Pediatr Diabetes; 2016 Aug; 17(5):311-8. PubMed ID: 26073672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.
    Ziegler R; Cavan DA; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
    Diabetes Care; 2013 Nov; 36(11):3613-9. PubMed ID: 23900590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Effect of an Automated Bolus Calculator in Pediatric Patients with Type 1 Diabetes on Multiple Daily Injections: The Expert Kids Study.
    Madsen JOB; Casteels K; Fieuws S; Kristensen K; Vanbrabant K; Ramon-Krauel M; Johannesen J;
    Diabetes Technol Ther; 2019 Jun; 21(6):322-328. PubMed ID: 31157566
    [No Abstract]   [Full Text] [Related]  

  • 6. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in type 1 diabetes mellitus patients treated with multiple daily insulin injections.
    Schwartz FL; Guo A; Marling CR; Shubrook JH
    J Diabetes Sci Technol; 2012 Jan; 6(1):150-2. PubMed ID: 22401333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a Novel, Remotely Connected Diabetes Management System Is Associated with Increased Treatment Satisfaction, Reduced Diabetes Distress, and Improved Glycemic Control in Individuals with Insulin-Treated Diabetes: First Results from the Personal Diabetes Management Study.
    Mora P; Buskirk A; Lyden M; Parkin CG; Borsa L; Petersen B
    Diabetes Technol Ther; 2017 Dec; 19(12):715-722. PubMed ID: 29027812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
    Shashaj B; Busetto E; Sulli N
    Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Barmer study: impact of standardized warming of the injection site to enhance insulin absorption and reduce prandial insulin requirements and hypoglycemia in obese patients with diabetes mellitus.
    Pfützner A; Hermanns N; Funke K; Forst T; Behnke T; Bitton G; Nagar R; Raz I; Haak T
    Curr Med Res Opin; 2014 May; 30(5):753-60. PubMed ID: 24392996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.
    Davis SN; Horton ES; Battelino T; Rubin RR; Schulman KA; Tamborlane WV
    Diabetes Technol Ther; 2010 Apr; 12(4):249-55. PubMed ID: 20210562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.
    Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Hendrieckx C; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Speight J; Trawley S; Ward GM; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2016 Dec; 18(12):772-783. PubMed ID: 27835037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA; Zinman B; Campos RV; Strack T;
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneous injections in patients with type I diabetes.
    Haardt MJ; Selam JL; Slama G; Bethoux JP; Dorange C; Mace B; Ramaniche ML; Bruzzo F
    Diabetes Care; 1994 Aug; 17(8):847-51. PubMed ID: 7956629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the use of a multifunctional remotely controlled insulin pump: multicenter observational study.
    Boizel R; Pinget M; Lachgar K; Parkin CG; Grulet H; Guillon-Metz F; Weissmann J
    J Diabetes Sci Technol; 2014 Nov; 8(6):1145-50. PubMed ID: 25107708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Efficacy of an Adaptive Bolus Calculator for Type 1 Diabetes: A Randomized Controlled Crossover Study.
    Unsworth R; Armiger R; Jugnee N; Thomas M; Herrero P; Georgiou P; Oliver N; Reddy M
    Diabetes Technol Ther; 2023 Jun; 25(6):414-425. PubMed ID: 37017468
    [No Abstract]   [Full Text] [Related]  

  • 19. Unknown Safety and Efficacy of Smartphone Bolus Calculator Apps Puts Patients at Risk for Severe Adverse Outcomes.
    Hirsch IB; Parkin CG
    J Diabetes Sci Technol; 2016 Jul; 10(4):977-80. PubMed ID: 26798082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a Smart Insulin Pen Cap for the Management of Patients with Uncontrolled Type 2 Diabetes: A Randomized Cross-Over Trial.
    Galindo RJ; Ramos C; Cardona S; Vellanki P; Davis GM; Oladejo O; Albury B; Dhruv N; Peng L; Umpierrez GE
    J Diabetes Sci Technol; 2023 Jan; 17(1):201-207. PubMed ID: 34293955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.